• Like
  • Comment
  • Favorite

Bellway's Strong Order Book Supports Guidance -- Market Talk

Dow Jones02-11

0825 GMT - Bellway is on track to deliver on full-year guidance at the halfway mark but this robust performance is at odds with its subdued share price performance, RBC Capital Markets analyst Anthony Codling says in a note. The underlying housing market appears to be stronger than what investors think it is, Codling says. Despite a rise in mortgage rates, customer demand and pricing remained firm. The forward order book's value of 1.31 billion pounds is 30% above 2024's levels, and implies a forward order book average sale price that is 9% higher year-on-year, he says. Shares are down 6.3% at 2,402 pence and are down 3.6% in the year to date. (anthony.orunagoriainoff@dowjones.com)

 

(END) Dow Jones Newswires

February 11, 2025 03:25 ET (08:25 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet

7x24

  • 05:00

    Kesko - Sales Increased by 4.7% in March, or by 3.9% in Comparable Terms.

  • 05:00

    Kesko - Sales in March 2025 Totalled EUR 1,049.7 Mln, Representing an Increase of 4.7%.

  • 05:00

    Finland March CPI +0.5% Yr/Yr -Statistics Finland

  • 05:00

    Ageas Sa - Transaction to Generate Cost Savings Exceeding GBP 100 Million per Annum

  • 05:00

    Ageas Sa - Transaction Completion Expected in 2H 2025, Subject to Regulatory Approvals